Doctor profile · Federal record
Dr. MATTHEW GERMAN, M.D.
Infectious Disease Physician (CMS: INFECTIOUS DISEASE) · CHESTERFIELD, MO
- NPI 1073628871
- Accepts Medicare
- 38 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
222 S WOODS MILL RD, SUITE 750
CHESTERFIELD, MO 630173625
(314) 205-6600
fax (314) 434-5939
Credentials & registration
- NPI registered
- August 2006 — 20 yrs on file
- Profile last updated
- August 6, 2015
- Year of graduation
- 1988 — 38 yrs since
- Specialty taxonomy
- 207RI0200X — NUCC code
- State license (1)
- Missouri #R6P06
- Medicaid
- MO #203166715
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1073628871. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
681
Distinct HCPCS
7
Medicare allowed
$62,871
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 310 | 87 | $78 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 103 | 21 | $118 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 80 | 60 | $89 | |
99221 |
Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 68 | 66 | $82 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 53 | 33 | $126 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 38 | 34 | $129 | |
99238 |
Hospital discharge day management, 30 minutes or less | 29 | 29 | $80 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 106. This provider delivers 6.4× the peer median.Open Payments
Industry payments received
All-time total
$2,204
Transactions
91
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ViiV Healthcare Company | 31 | $695.49 | |
| ABBVIE INC. | 15 | $286.13 | |
| Gilead Sciences, Inc. | 9 | $184.36 | |
| Merck Sharp & Dohme LLC | 5 | $152.84 | |
| AIMMUNE THERAPEUTICS, INC. | 7 | $137.01 | |
| Abbott Laboratories | 1 | $105.56 | |
| Insmed, Inc. | 5 | $101.29 | |
| EMD Serono, Inc. | 5 | $96.08 | |
| Theratechnologies Inc. | 3 | $79.26 | |
| Paratek Pharmaceuticals, Inc. | 3 | $71.14 | |
| Amgen Inc. | 2 | $44.22 | |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36.77 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28.86 | |
| UCB, Inc. | 1 | $22.71 | |
| Esperion Therapeutics, Inc. | 1 | $22.35 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,432
Patients
162
Total drug cost
$1,896,039
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Biktarvy (Bictegrav/Emtricit/Tenofov Ala) | Brand | 290 | 38 | $1,248,747 |
| Rosuvastatin Calcium | Generic | 225 | 40 | $4,136 |
| Amlodipine Besylate | Generic | 158 | 28 | $1,117 |
| Dovato (Dolutegravir Sodium/Lamivudine) | Brand | 105 | 18 | $328,282 |
| Alprazolam | Generic | 86 | 11 | $789 |
| Tivicay (Dolutegravir Sodium) | Brand | 71 | 0 | $161,510 |
| Gabapentin | Generic | 63 | 0 | $1,296 |
| Lisinopril | Generic | 62 | 0 | $468 |
| Omeprazole | Generic | 60 | 13 | $825 |
| Metoprolol Succinate | Generic | 55 | 0 | $642 |